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Alzheimer’s disease (AD) is one of the most serious human, medical, and
socioeconomic burdens. Here we tested the hypothesis that a rat model of AD
(Samaritan; Taconic Pharmaceuticals, USA) based on the application of amyloid
beta42 (Abeta42) and the pro-oxidative substances ferrous sulfate heptahydrate and
L-buthionine-(S, R)-sulfoximine, will exhibit cognitive deficits and disruption of the
glutamatergic and cholinergic systems in the brain. Behavioral methods included
the Morris water maze (MWM; long-term memory version) and the active allothetic
place avoidance (AAPA) task (acquisition and reversal), testing spatial memory and
different aspects of hippocampal function. Neurochemical methods included testing
of the NR1/NR2A/NR2B subunits of NMDA receptors in the frontal cortex and CHT1
transporters in the hippocampus, in both cases in the right and left hemisphere
separately. Our results show that Samaritan rats™ exhibit marked impairment in
both the MWM and active place avoidance tasks, suggesting a deficit of spatial
learning and memory. Moreover, Samaritan rats exhibited significant changes in
NR2A expression and CHT1 activity compared to controls rats, mimicking the
situation in patients with early stage AD. Taken together, our results corroborate
the hypothesis that Samaritan rats are a promising model of AD in its early
stages.
Keywords: animal model, Alzheimer’s disease, sporadic AD, learning and memory, cognition, neurochemistry
of the acetylcholine system, hippocampus
Abbreviations: AAPA, active allothetic place avoidance; Abeta, amyloid beta; AD, Alzheimer’s disease; CHT1, high-affinity
choline transporter; HACU, high-affinity choline uptake; MWM, Morris water maze; NMDA, N-methyl-D-aspartate.
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INTRODUCTION
Alzheimer’s disease (AD) is a serious neuropsychiatric disorder,
invariably resulting in the death of the patient, preceded by
a slow and excruciating deterioration of memory, cognitive
abilities and personality, which constitutes a serious burden
not only for patients but also for their relatives and the whole
society. With the ageing population in many countries, the
number of people suffering from AD will increase enormously.
The exact etiology of the disease is not known, although it
presents with extracellular plaques of amyloid beta (Abeta)
peptides and intracellular tangles of protein tau (Reiman,
2014). Both these factors are suspected to play an important
role in disease progression (Spires-Jones and Hyman, 2014).
Apart from protein accumulations, AD is accompanied by
neuroinflammation, oxidative stress, and neurodegeneration
of the cholinergic, noradrenergic and serotonergic projections
(Wenk, 2003). Many scientists today are not convinced that
the pathological accumulation of proteins is the primary cause
of the disease process, and consider neuroinflammation and
disrupted axonal transport as possible factors that may be present
prior to the clinical onset of the disorder (Schuitemaker et al.,
2009; Ye et al., 2012). Multiple changes reaching beyond the
simple description given above have been detected in AD brain
neurochemistry (e.g., Cai and Ratka, 2012). These changes can
be studied primarily in animal models and post mortem studies,
since the living human brain is barely accessible to biochemical
examination.
There are two basic forms of AD: familial and sporadic.
The familial form is very rare and is related to inherited gene
mutations (Rossor et al., 1993). The sporadic form represents
a vast majority of AD cases (Piaceri et al., 2013) and typically
occurs at more advanced age. There are reports that this type
may start in middle age as well, although this is not very
common (Reiman, 2014). A vast majority of transgenic models
of AD carry various mutations in Abeta, tau or presenilin (Do
Carmo and Cuello, 2013). In this respect, these models are closer
to the familial, rather than sporadic, form of AD. However,
valid models of sporadic AD, which may not necessarily
involve gene mutations, are of high importance for basic and
applied research focused on AD (Lecanu and Papadopoulos,
2013).
Beside massive neurodegeneration and neurochemical and
anatomical changes in the brain, patients with AD exhibit severe
learning and memory deficits. These include disorientation and
other impairments affecting the cognitive domain (Reiman,
2014). Therefore, appropriately sensitive behavioral testing
of these models coupled to detailed examinations of brain
biochemistry is very important.
For the present study we used a rat model of AD based on the
chronic (28 days) intracerebroventricular application of Abeta42
and the pro-oxidative substances ferrous sulfate heptahydrate
and L-buthionine-(S, R)-sulfoximine (the Samaritan Alzheimer’s
Rat Model; Taconic Pharmaceuticals, USA, described in Lecanu
et al., 2006). We must note that this model is mainly
focused on mimicking the symptoms of the disease, and is
therefore not suitable for elucidating its etiology. A previous
study (Lecanu et al., 2006) documented impairments of
working memory and typical neuropathological changes in this
model. We attempted to characterize the model further, using
two independent spatial cognitive tasks focused mostly on
hippocampal function together with a neurochemical analysis of
the hippocampus.
Our working hypothesis was that the Samaritan rat model
of sporadic AD would present cognitive deficits in spatial
tasks and alterations in brain glutamatergic and cholinergic
neurotransmitter systems.
The behavioral tasks we employed, the Morris water maze
(MWM) and the active allothetic place avoidance task (AAPA),
place very different demands on hippocampal functions. Solving
the MWM requires storing precise representation of spatial
relationships in order to locate a small, hidden goal. In the AAPA,
on the other hand, the major hippocampus-dependent task
involves organizing the spatial information into two conflicting
frames, and selection of the relevant one. Impairments of
hippocampal function therefore impact preferentially memory
retrieval in the MWM, whereas in the AAPA, new learning is
disrupted before retrieval (Kubík and Fenton, 2005). Therefore,
we were interested in the possibility of differential impacts




Young adult male Long-Evans rats were obtained from Taconic
Pharmaceuticals, USA (with the patented commercial name
Samaritan ratTM; see Lecanu et al., 2006), where they underwent
the following procedure prior to delivery. The experimental
animals received an infusion of Abeta42 (15 µM) and two pro-
oxidative substances, ferrous sulfate heptahydrate (1 mM) and
L-buthionine-(S, R)-sulfoximine (12 mM), dissolved in artificial
cerebrospinal fluid. The solution was applied chronically
(4 weeks at a rate of 2.5 µl/h) via an osmotic pump connected to
a permanent cannula inserted into the left cerebral ventricle, to
induce AD-like brain pathology. This procedure was described
in detail by Lecanu et al. (2006). Control rats were sham-treated
(infused by the solvent without active substances). Treatments
started at the age of 7 postnatal weeks, and lasted for 4
weeks.
At the age of 8 weeks, the animals were transported
from Taconic Pharmaceuticals to the Institute of Physiology,
Academy of Sciences of the Czech Republic, where they were
allowed a 2-week acclimatization period. Animals were housed
in an accredited animal room with constant humidity (50%),
temperature (22 ± 1◦C) and a regular light-dark cycle (lights on
between 6:00 and 18:00). Animals from both groups were tested
in an alternating order, to exclude bias from potential circadian
changes in performance.
All experiments were approved by the local Committee for
Animal Protection and complied with the Animal Protection
Act of the Czech Republic, EU directive (2010/63/EC). Access to
water and standard rat food was ad libitum.
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TABLE 1 | Experimental design.




Arrival to the animal
room, acclimation period,
handling
Morris Water Maze AAPA Brain tissue
sampling4 days 1 day probe 1 day visible 2 days 5 days 5 days
acquisition trial platform habituation acquisition reversal
From an initial total of 21 animals, two died, and one
of the animals from the experimental group had to be
excluded because of non-standard behavior (the animal was
obviously anxious, aggressive when manipulated and attempted
to escape from the testing apparatus). Therefore, nine Samaritan
and ten control rats, aged 11–22 weeks, were used in the
study.
Study Design
After the acclimatization period at the Institute of Physiology
AS CR, animals were handled for 5 days (handling included
habituation to human touch, holding and manipulation by the
experimenters for 5–10 min per day) and then subjected to
MWM testing for 6 days starting at the age of 11 weeks,
and then tested in an AAPA test with reversal, starting at
the age of 20 weeks. After completion of the behavioral
studies, the rats were sacrificed at the age of 22 weeks
and subsequent neurochemical analyses were conducted post
mortem. Table 1 shows the timing of the most important
experimental steps.
The Morris Water Maze (MWM)
The MWM is a classical test of precise place navigation and
memory (Morris, 1981; Stuchlik et al., 2007a; Petrásek et al.,
2014a), widely used in models of cognitive disorders. We
used a reference memory protocol with four-day training,
followed by a probe trial at Day 5 and visible platform
testing at Day 6. The MVM (Morris, 1981; Stuchlik et al.,
2007b; Petrásek et al., 2014a; reviewed in D’Hooge and De
Deyn, 2001) consisted of a gray circular pool (180 cm in
diameter) filled with water at a temperature of 21 ± 2◦C
to a depth of 35 cm. The water was rendered opaque by
adding a small amount of non-toxic white paint (Primalex,
PPG Deco; Czech Republic). The maze was located in a
room providing an abundance of extra-maze cues. Swimming
trajectories were monitored by an overhead camera connected
to a digital tracking system and data acquisition program
(Tracker, Biosignal Group, NY, USA). The maze contained a
transparent plastic platform (10 cm in diameter) located in
the center of the NE quadrant (the quadrants were labelled
based on arbitrary compass directions) in acquisition sessions
of the hidden-platform phase. In total, there were four daily
sessions of hidden-platform testing in the MWM with the
same platform position. The rats were released for six swims
per session, separated by 15-min intervals, from different start
locations, the sequence of which was changed pseudo-randomly
for each daily session. Probe trial (60-s swims with the platform
removed from the pool) was given in the fifth daily session to
demonstrate the remembered platform position (one session, one
swim).
In the visible platform testing (one daily session) the platform
was raised above the surface and marked by a dark rim. The
animals underwent eight swims in 15-min intervals, always
being released from pseudorandomly chosen places around the
periphery. The platform position was located in the SE. All
MWM experiments were done between 18:00 and 23:00, i.e.,
during the dark phase of the day.
Active Allothetic Place Avoidance (AAPA)
AAPA is a spatial task on a dry arena (Czéh et al., 2001),
constituting prototype of a dynamic memory test (Stuchlik,
2014). Compared to the MWM, it places lower demands
on precise spatial navigation, but on the other hand, it
requires segregation of spatial frames, a skill that is considered
equivalent to human cognitive coordination (Wesierska et al.,
2005; for detailed conceptualization of this term see Phillips
and Silverstein, 2003). We also included reversal training,
sensitive to cognitive flexibility impairments (Petrásek et al.,
2014a,b). The AAPA task is a test of both spatial abilities and
executive functions, requiring animals to maintain two spatial
representations and choose the relevant one, and is especially
sensitive to subtle damages of hippocampal function (Kubík and
Fenton, 2005; Stuchlik et al., 2013; Petrásek et al., 2014a).
The active place avoidance apparatus (Carousel; originally
described by Bures et al., 1997; Fenton et al., 1998; reviewed in
Stuchlik et al., 2013, 2014) was a smooth metallic arena (82 cm
in diameter), enclosed with a transparent Plexiglas wall (for
details of the apparatus and procedures see Stuchlik et al., 2007a;
Stuchlik and Vales, 2008; Lobellova et al., 2013). At the beginning
of each session, a rat was placed in the center of the arena, which
rotated constantly at one revolution per minute. A 60-degree to-
be-avoided sector was defined in the coordinate frame of the
room by the computer-based tracking system (Tracker, Biosignal
Group, NY, USA), which also recorded the positions of the
rat and the arena (which were both marked by infrared LED
diodes) at a sampling rate of 25 Hz. Each entrance into the
sector lasting more than 300 ms was punished by mild electric
footshocks (AC, 50 Hz, repeated every 1200 ms until the rat
left the sector) delivered by the tracking system. The intensity
of the shock was individualized for each rat (0, 3–0, 7 mA),
to ensure an escape reaction while avoiding freezing caused by
excessive pain. The shocks were administered through a cable
attached to a harness on the back of the rat and connected to
a conductive subcutaneous implant. The current was perceived
by the rat at places of high-impedance contact between the
paws and the grounded metallic floor. The trajectories were
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digitized and recorded on a PC, allowing off-line reconstruction
and analysis of the animal’s trajectory (Track Analysis, Biosignal
Group, NY, USA; Carousel Maze Manager, Bahník, 2014) both
in the coordinate frame of the room and in the coordinate frame
of the rotating arena.
Since the arena rotated, the rat had tomove actively away from
the sector in the direction opposite to arena rotation, otherwise
it would be passively transported into the shock sector. For
successful avoidance, the animal had to distinguish the distant
room-frame cues, which could be used to locate and avoid the
sector, from the irrelevant, arena-frame cues (i. e. scent marks),
which moved relative to the sector position and were thus
misleading.
Testing began with two habituation sessions, one on a stable
arena, the other with rotation, to observe the spontaneous
behavior of the animals and allow them to become accustomed
to the testing procedure. Ten daily 20-min sessions of active
place avoidance testing were conducted separated by 24-h
inter-trial intervals. The initial five sessions were considered
acquisition sessions, and were followed by five reversal
sessions with the sector position shifted by 180 degrees.
Carousel maze testing was conducted during daylight hours
(10:00–18:00).
Neurochemical Analysis of the Brain
Tissue
Neurochemical analysis was focused on changes in the cortical
glutamatergic and hippocampal cholinergic neurotransmitter
systems, both involved in learning and memory processes.
With respect to changes in the glutamatergic system in AD,
the data in the literature support a two-stage mechanism.
In particular, N-methyl-D-aspartate (NMDA) receptors seem
to be hyperactive in early stages but rather hypoactive in
later stages of the disease (e.g., Butterfield and Pocernich,
2003). Since NMDA receptors are heteromeric complexes
of particular subunits and the subunit composition can be
changed among others under pathological conditions (Cull-
Candy et al., 2001), we decided to evaluate the Samaritan
rat model via the expression of the NR1, NR2A and
NR2B subunits of NMDA receptors. Although a gradual loss
of cholinergic neurons in the nucleus basalis of Meynert
reflects a gradual deterioration of memory and cognitive
processes in AD (Arendt et al., 1983), changes in the
activity of hippocampal or cortical presynaptic cholinergic
nerve terminals also suggest possible two-stage mechanism.
This activity can be estimated via measurements of Na+-
dependent, high-affinity choline uptake (HACU) operating
via CHT1 transporters. The HACU levels are increased in
early stages of AD, probably via a compensatory reaction
to impairments of the cholinergic basal forebrain system
(Slotkin et al., 1990). On the contrary, the activity of CHT1
is markedly decreased in later stages of AD (Sims et al.,
1983). Similarly, the number of membrane-bound CHT1
transporters estimated by means of the specific binding of
[3H]hemicholinium-3 ([3H]HC-3), a selective and competitive
inhibitor of HACU, is initially enhanced (Slotkin et al., 1990)
but later attenuated (Pascual et al., 1991; Rodríguez-Puertas et al.,
1994).
Tissue Sampling
Rats were sacrificed by cervical dislocation, decapitated and the
brains rapidly removed. The frontal cortices and hippocampi,
separately from the right (R) and left (L) hemisphere, were
dissected and weighed. The frontal cortices were packed in
aluminum foil and frozen at −40◦C until assayed (no more than
2 weeks later), while the hippocampi were immediately used for
preparation of synaptosomes.
Expressions of the NMDA Receptor Subunits NR1,
NR2A and NR2B by Western Blotting
The frontal cortices were homogenized in 1.0 mL of lysis buffer
(320 mM sucrose; 10 mM Tris, pH 7.4; 0.2 mM EDTA; 2 mM
PMSF; 1 mM 2-mercaptoethanol and a cocktail of protease
inhibitors, Sigma). Crude synaptosomal (P2) fractions were
isolated from homogenates and resuspended in a loading buffer
(63 mM Tris; 10% glycerol; 2% SDS; 5% 2-mercaptoethanol
and 0.01% bromophenol blue). The protein concentration
was determined by the Bradford method using bovine serum
albumin (BSA) as the standard (Bio-Rad, CA, USA). The
resuspended material was subjected to electrophoresis in a
7.5% polyacrylamide gel (Criterion Cell, Bio-Rad, CA, USA),
followed by electroblotting in Criterion blotter (Bio-Rad, USA).
Non-specific binding was blocked with 3% BSA dissolved
in TBS-T buffer. Blots were incubated overnight with anti-
NMDAR1 (1:100; Millipore, MA, USA) or for 2 h with anti-
NMDAR2A/2B (1:500; Millipore, MA, USA) primary antibodies.
For loading control, blots were treated with an anti-α-tubulin
antibody (1:1000; Exbio, CZ, USA) for 1 h. Then, the
blots were washed in TBS-T buffer and incubated for 1 h
with a horseradish peroxidase-conjugated secondary antibody
(1:3000; Dako, Denmark). Detections were performed with a
chemiluminescent substrate (Pierce, WI, USA) and evaluated by
the Gel Doc Analysis system (Bio-Rad, CA, USA).
Preparation of Hippocampal Synaptosomes
The hippocampi from individual animals were separately
transferred to 0.32 M sucrose and immediately used for
preparation of synaptosomes using glass-Teflon Potter’s Braun
homogenizer, 0.32 M sucrose, an Universal 32R centrifuge
(1000 g for 10min at 4◦C) and a Beckman J2-HS centrifuge (twice
20,000 g for 20 min at 4◦C) in accordance with our previous
studies (Kristofikova et al., 2004, 2010).
HACU Measurements
Hundred microlitres (100 µl) of synaptosomes were added to
880 µl of Krebs-Ringer-HEPES-glucose buffer (128 mM NaCl,
5 mM KCl, 2.7 mM CaCl2, 1.2 mM MgSO4, 5 mM glucose
and 10 mM HEPES, pH = 7.4) and incubated for 4 min at
37◦C with 20 µl of [3H]choline ([methyl-3H]choline chloride,
PerkinElmer). The final concentration of the radioisotope was 10
nM and that of total proteins (estimated by the Bradford method
with BSA as a standard) 150 µg/ml in all incubation mixtures.
The incubation was terminated by rapid cooling and filtration
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under vacuum (Whatman BF/B filters). HACU was defined by
its sensitivity to unlabeled HC-3 (RBI) and calculated as the
difference between the uptake in samples incubated without
and with 1 µM HC-3. The activity of samples was measured
on a multi-purpose scintillation counter LS 6500 (Beckman
Coulter) using Gold Star liquid scintillation cocktail (Meridian).
Remaining synaptosomes were stored at−40◦C and later used to
measure the specific binding of [3H]HC-3.
Measurements of the Specific Binding of [3H]HC-3
Twenty microlitres (20 µl) of synaptic membranes were
added to 170 µl of glycylglycine buffer (50 mM glycylglycine,
200 mM NaCl, pH = 7.8) and incubated for 30 min
at room temperature with 10 µl of [3H]HC-3 ([methyl-
3H]hemicholinium-3, diacetate salt, PerkinElmer). The final
concentration of the radioisotope was 20 nM and that of total
proteins was 150 µg/ml in all incubation mixtures. Parallel
incubations in the presence of 10 µM HC-3 were performed
to define the nonspecific binding. The titration and activity
measurement were performed as described above.
Measured Parameters and Statistical Evaluations
In the AAPA task, total distance traveled within a session served
as a measure of locomotor activity. Maximum avoidance time
per session (s) and number of errors (entrances into the to-
be-avoided sector) served as measures of cumulative within-
session performance. Finally, latency to the first entrance from
the beginning of the session (time to the first error) served
as a measure of between-session learning. For the MWM we
used total distance to reach the platform as a measure of
acquisition performance in all sessions except in the probe
trial. In the probe trials, where no platform was present, we
evaluated preference for the quadrant that previously contained
the platform.
Behavioral data from AAPA were analyzed separately for
acquisition and reversal by two-way analysis of variance
(ANOVA), with repeated measures on sessions and groups
as a between subject factor. In cases of non-normality of the
data (errors, maximum avoidance time and time to the first
error) the natural logarithm (ln) was used to normalize the data
distribution. Post hoc analysis was conducted with a Newman-
Keuls test. Data from the hidden platform testing in the MWM
were analyzed by mixed effects ANOVA, with repeated factors
of swims and sessions, and groups as a between-subject factor.
Data from the visible platform testing were analyzed by a two-
way ANOVA (groups × swims) with repeated measures on
swims. Data from the probe trial were analyzed with a two-
sample, two tailed t-test. In all behavioral tests, 8 Samaritan
rats and 10 controls were used. Missing values (i.e., tracks lost
due to technical errors) were treated by a case-wise deletion;
therefore, the degrees of freedom may differ for respective
measures.
Biochemical data were analyzed by ANOVA with repeated
measures with groups as a grouping factor and laterality
(differences between the R and L side) as a within factor, and
subsequently by one-way ANOVA. Differences between the
R and L side were also characterized by the index of laterality
[(L−R)/(L+R)]. This index is limited to zero when all the values
are not lateralized (marked asymmetry was defined in this study
by indexes of laterality > ± 0.090) or when the numbers of
markedly R/L animals (dominance of the R side) and L/R
animals (dominance of the L side) are approximately equal.
Data are presented as the mean ± standard errors of the mean
(SEM).
We also performed correlations between selected parameters
of neurochemical tests. We correlated the expressions of
NR1/NR2A/NR2B subunits of NMDA receptors, and CHT1
parameters (HACU and the specific binding of [3H]HC-3). For
the sake of simplicity and straightforwardness, we report only
significant correlations, and an absence of correlation is reported
only if it has biological significance, using Pearson’s correlation
(r and p values). The equality of correlation coefficients in
two groups was examined using the test based on Fisher’s




First we tested rats in the MMW (Figure 1). There were four
acquisition sessions in the hidden platform version of the MWM
with the platform located in the NE and pseudorandom starting
positions. In these sessions, Samaritan rats needed longer paths
to locate the platform, indicating that they were impaired. The
mixed effects ANOVA (groups × sessions × swims) revealed
a significant main effect of group (F(1,13) = 12.62; p < 0.05),
sessions (F(3,39) = 4.76; p< 0.05), swims (F(5,65) = 10.57; p< 0.05)
and interaction between groups and session (F(3,39) = 4.41;
p < 0.05). No other interactions, including a triple interaction
between swims, sessions and groups, were detected. The total
distance to reach the platform in a particular session is illustrated
in Figure 1A-left; though individual swims are not depicted, the
total distance decreased in both groups for subsequent swims
each day.
When examining the latency to reach the platform, the
results were similar. The mixed effects ANOVA (groups ×
sessions × swims) revealed a significant main effect of group
(F(1,16) = 4.93; p< 0.05), sessions (F(3,48) = 13.28 p< 0.05), swims
(F(5,80) = 4.47; p < 0.05) and interaction between groups and
swims (F(5,80) = 2.63; p < 0.05). No other interactions, including
a triple interaction between swims, sessions and groups, were
detected.
Second, a probe trial was conducted during session five of
the MWM. A two-sample t-test comparing the performance
between groups revealed decreased time spent in the target
quadrant that previously contained the platform (T(1,16) = 10.13;
p < 0.05). As can be seen from Figure 1B, the performance
of control rats was above the level of chance (15 s for a
randomly swimming rat), but the performance of Samaritan
rats was below chance. This suggests that remembrance of
the platform position was impaired in the Samaritan group.
(Figure 1B) The low target sector preference of the Samaritan
group in the probe trial was probably linked to their inferior
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FIGURE 1 | Results from the Morris water maze (MWM). (A) Total distance to reach the platform. In four daily acquisition sessions with a hidden platform in a
stable position (d01–d04), Samaritan rats were significantly impaired and their performance did not improve during subsequent sessions, suggesting severe
behavioral impairments. The visible platform test showed that both groups had both the motivation and physical ability to reach the platform (the apparent trend
towards poorer performance in the Samaritan group was not statistically significant). (B) The probe trial (a single swim without a platform) was performed on the fifth
session, after hidden platform training but before visible platform testing. Samaritan rats spent significantly less time in the quadrant that had previously contained the
platform, which suggests an impairment of memory or spatial navigation. Their performance was even below the expected random value (15 s), as indicated by the
dashed line. Columns in the charts show group means, and SEM is indicated by the error bars. Significant differences between groups or sessions at p < 0.05 as
evaluated by a t-test on session-averaged data are indicated by an asterisk (*), n.s. indicates a non-significant result.
searching strategy. Visual inspection of the data suggested
much higher thigmotaxis in the Samaritan group, and a slight
preference for the quadrant opposite to the target (where the
starting position was located). We thus evaluated thigmotaxis
(measured as the distance from the center of the maze) by
a two-sample t-test, which confirmed that the Samaritan rats
tended to spend more time on the periphery (T(1,16) = 2.78;
p< 0.05).
Finally, we conducted a visible platform test (Figure 1A-right,
showing the mean path needed to find the platform for each
day), consisting of eight swims in 1 day. The two-way ANOVA
(groups × swims) failed to detect a significant main effect of
group (F(1,14) = 3.44; p > 0.05), but a significant main effect of
swims was found (F(7,98) = 3.21; p < 0.05). Visual inspection
of the data indicated poorer performance in the initial swims
(not shown), before the animals adjusted to the new task rules;
however, there was no significant interaction (F(7,98) = 1.65;
p > 0.05). For the time to reach the platform, there was no
significant effect of group (F(1,16) = 3.93; p > 0.05), but there
was a significant effect of swims (F(7,112) = 5.37; p < 0.05.
Again, no significant interaction was present (F(7,112) = 2.06;
p > 0.05).
Active Allothetic Place Avoidance
Habituation Sessions
During the habituation phase (two sessions; Figure 2-left parts of
panels), no effect of groups was detected (F(1,15) = 2.35; p > 0.05).
There was, however, a significant effect of days, with animals
walking more on the second day of habituation on the rotating
arena (F(1,15) = 4.74; p< 0.05). No interaction between the factors
of group and day was detected. Place navigation parameters were
not evaluated in this phase, since there were no shocks applied
and therefore no avoidance.
Acquisition Sessions
During the acquisition phase, there was no effect of groups
on total distance (F(1,16) = 1.84; p > 0.05); however, ANOVA
revealed a significant effect of sessions (F(4,64) = 3.09; p < 0.05)
and a significant interaction (F(4,64) = 4.43; p < 0.05). The
Newman-Keuls post hoc test on session term revealed that
the distance was higher in the last three sessions, probably
as an adaptation to the task. Analysis of the interaction term
demonstrated that while Samaritan rats had stable locomotion in
all acquisition sessions, the control group gradually increased the
total distance traveled (Figure 2A). Visual inspection of the data
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FIGURE 2 | Results from the Carousel maze. The Carousel maze testing consisted of two habituation sessions (d01–02), acquisition (d03–07) and reversal
training (d08–12). (A) Total distance walked is a measure of locomotor activity. In the habituation sessions, the difference between groups was not significant, but
locomotion increased in the second session (with a rotating arena) relative to the first (with a stable arena). In the acquisition phase, the effect of group was also not
significant; however, the control group gradually increased its locomotion, whereas the locomotion of the Samaritan rats was stable. In the reversal stage, no
difference was found. (B) Maximum avoidance time indicates the longest period of successful avoidance during a session. Again, the effect of groups was not
significant, but there was a significant interaction suggesting slower learning in the Samaritan group in the acquisition phase. In the reversal phase, neither the group
effect nor interaction was significant, despite the apparent trend visible in the graph. (C) Number of errors (entrances into the sector) is another measure of avoidance
behavior. The difference between groups was again not significant, but a significant interaction indicated slower learning and poorer final performance in Samaritans
during the acquisition phase. In reversal, the apparent tendency toward increased number of errors in the Samaritan group remained non-significant. (D) Time to first
error is a measure of between-session (long-term) memory. There was only a trend for group difference, but a significant interaction term again indicated poorer final
performance in Samaritans during acquisition. There was no significant difference in the reversal phase, which may have been caused by the large variance in this
parameter. Bars or data points in the charts show group means, and SEM is indicated by the error bars. Significant differences between groups at p < 0.05 as
evaluated by the t-test on session-averaged data are indicated by an asterisk (∗), n.s. indicates a non-significant result.
showed that some control animals exhibited passive behavior
during the first avoidance session, but they gradually abandoned
this strategy, and all of them were able to achieve successful
avoidance. In the Samaritan group, this passive behavior was
less common in the beginning, but several rats were not able
to achieve the avoiding behavior at all, although some others
were.
Analysis of the maximum avoidance time again revealed a
significant main effect of sessions (F(4,64) = 16.19; p < 0.05)
but not groups (F(1,16) = 1.79; p > 0.05), with the interaction
term being significant (F(4,64) = 5.70; p < 0.05). Post hoc
test on sessions revealed that again, maximum avoidance time
was significantly increased in last three acquisition sessions
(p < 0.05). Analysis of the interaction term revealed that
Samaritan rats had lower maximum avoidance times at the end
of acquisition than controls (p< 0.05; Figure 2B).
Analysis of the number of errors revealed a significant main
effect of sessions (F(4,56) = 30.90; p < 0, 05), but not group
(F(1,14) = 2.93; p > 0.05]; however, the interaction term was
significant (F(4,56) = 3.02; p < 0.05. The post hoc test on the
session factor revealed a lower number of errors in last three
sessions compared to the first two sessions (p < 0.05). Analysis
of the interaction term showed that Samaritan rats did not
achieve the same level of final performance as controls (p< 0.05;
Figure 2C).
The two-way ANOVA conducted on the data for time-to-the-
first-error revealed a significant effect of sessions (F(4,64) = 9.85;
p < 0.05) and the interaction term (F(4,64) = 3.26; p < 0.05).
The effect of group exhibited only a trend (F(1,16) = 3.98;
p = 0.06), likely due to the high variance in the data. The
post hoc test of the session factor showed that rats in the last
two sessions had increased time to the first error compared to
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FIGURE 3 | Results of western blotting. Representative images of samples
from the L hemisphere were used (all data are presented in Table 2).
the three initial sessions. Visual analysis of the group factor
trend showed that control groups improved in between-session
memory compared to Samaritan rats, although there was high
variation. The post hoc analysis of the interaction term showed
impaired between-session memory in Samaritan rats compared
to controls (Figure 2D).
All these data suggest that the AD model animals were
impaired in acquisition sessions for all measured spatial
parameters, including the total distance (significant interaction
term).
Reversal Sessions
Total distance in the reversal sessions was not affected by any
factor, nor was any interaction detected (all p > 0.05). This
suggests that animals were already accommodated to the task and
did not have locomotor disabilities (Figure 2A-right). The two-
way ANOVA conducted on maximum avoidance time revealed
only a main effect of sessions (F(4,60) = 6.17; p < 0.05). No
other terms (groups, interaction) were significant (all ps> 0.05).
This again suggests that there were no between group differences
in this parameters in the reversal sessions, although a visual
trend of an increased number of errors in Samaritan rats can
be seen (Figure 2B-right). The number of errors was affected
only by sessions (F(4,44) = 14.59; p < 0.05); no other effects were
significant (all ps > 0.05). The post hoc analysis of the session
factor showed that in the first reversal session this parameter was
worse than in subsequent sessions, when it gradually decreased
(Figure 2C-right). There seems to be a trend in interaction,
but this was not significant, probably due to high variation.
Time to the first error was not affected by any factor, and this
parameter also showed high variation (all ps > 0.05; Figure 2D-
right).
Neurochemical Analysis
Table 2 shows the expression levels of NR1/NR2A/NR2B
in the R and L frontal cortices. For representative image
of western blot results, see Figure 3. In the sham-operated
Long Evans controls, no marked asymmetries were found
in NR1 (index of laterality = +0.005) or in NR2A subunit
(index of laterality = −0.010). On the other hand, mild L/R
dominance was observed in the NR2B subunit (index of
laterality = +0.056, there was an increase to 112% in the L
TABLE 2 | Expression of NR1/NR2A/NR2B subunits of NMDA receptors in
the frontal cortex.
Groups n R L L−R/L+R
NR1
Sham-operated rats 10 1.002 ± 0.006 1.009 ± 0.004 0.005 ± 0.003
Samaritan rats 8 0.985 ± 0.014 1.009 ± 0.004 0.013 ± 0.007
One-way ANOVA F(1,16) = 1.29, F(1,16) = 0.00, F(1,16) = 1.11,
p = 0.2728 p = 0.9906 p = 0.3068
NR2A
Sham-operated rats 10 0.856 ± 0.004 0.840 ± 0.003 −0.010 ± 0.003
Samaritan rats 8 0.864 ± 0.006 0.857 ± 0.005* −0.005 ± 0.004
One-way ANOVA F(1,16) = 1.46, F(1,16) = 7.56, F(1,16) = 0.91,
p = 0.2439 p = 0.0142 p = 0.3548
NR2B
Sham-operated rats 10 0.850 ± 0.020 0.948 ± 0.007 0.056 ± 0.015
Samaritan rats 8 0.883 ± 0.009 0.950 ± 0.007 0.036 ± 0.008
One-way ANOVA F(1,16) = 1.91, F(1,16) = 0.03, F(1,16) = 1.16,
p = 0.1863 p = 0.8540 p = 0.2969
Mean ± SEM. Expressions of NMDA receptor subunits were estimated separately
in the right (R) and left (L) frontal cortices. Results of ANOVA with repeated
measures: NR1 groups: F(1,16) = 0.93, p = 0.3499, laterality: F(1,16) = 5.22,
p = 0.0363∗, interaction: F(1,16) = 1.45, p = 0.2455. NR2A groups: F(1,16) = 6.43,
p = 0.0220∗, laterality: F(1,16) = 7.89, p = 0.0126∗, interaction: F(1,16) = 0.96,
p = 0.3421. NR2B groups: F(1,16) = 2.85, p = 0.1107, laterality: F(1,16) = 28.47,
p = 0.0001∗∗∗, interaction: F(1,16) = 1.04, p = 0.3220. ∗p < 0.050, ∗∗∗p < 0.001.
compared to the R cortex, and the results of ANOVA with
repeated measures for laterality was significant, p < 0.001). In
Samaritan rats compared to the controls, results of ANOVA
with repeated measures and one-way ANOVA only showed
a significant change in the NR2A subunit (an increase to
102% in the L side of Samaritan rats). Although the results
of the global test also suggested possible effects of laterality
in the NR1 and NR2B subunits (with a drop to 98% of NR1
and an increase to 104% of NR2B in Samaritan rats, in both
cases in the R side), results of one-way ANOVA did not
support this.
Table 3 demonstrates the results of the HACU and [3H]HC-
3 specific binding measurements in the R and L hippocampi.
In sham-operated Long Evans controls, the data indicated a
marked R/L dominance of HACU activity (index of laterality
−0.094, an increase approximately to 119% in the R compared
to the L hippocampus, and significant ANOVA with repeated
measures for laterality p < 0.05). On the other hand, R/L
dominance was not found in [3H]HC-3 specific binding (index
of laterality -0.027, and an insignificant increase to 108%
in the R compared to L side). When comparing Samaritan
rats to controls, results of ANOVA with repeated measures
indicated significant differences between groups in HACU values
(increases to 142% in the R side and to 132% in the L side of
Samaritan rats); nevertheless, the results of one-way ANOVA
were only borderline significant.
No differences between groups were observed in the specific
binding of [3H]HC-3.
Correlation Analysis
The results of correlation analysis from biochemical experiments
are summarized in Table 4. In sham-operated controls, there
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TABLE 3 | Activity and number of synaptic CHT1 transporters in the
hippocampus.
Groups n R L L−R/L+R
HACU
Sham-operated rats 9 226.2 ± 24.0 189.7 ± 24.4 −0.094 ± 0.057
Samaritan rats 9 321.1 ± 38.6 251.1 ± 27.9 −0.114 ± 0.064
One-way ANOVA F(1,16) = 4.36, F(1,16) = 2.74, F(1,16) = 0.05,
p = 0.0532 p = 0.1174 p = 0.8191
[3H]HC-3
Sham-operated rats 9 4465.1 ± 674.3 4123.5 ± 466.5 −0.027 ± 0.033
Samaritan rats 9 4520.3 ± 540.8 4532.5 ± 333.4 0.020 ± 0.048
One-way ANOVA F(1,16) = 0.00, F(1,16) = 0.51, F(1,16) = 0.62,
p = 0.9499 p = 0.4859 p = 0.4408
Mean± SEM. The activity of the high-affinity choline uptake (HACU) was estimated
in synaptosomes isolated separately from the right (R) and left (L) hippocampi and
expressed as fmoles/4 min/mg or proteins. The specific binding of (3H)HC-3 was
estimated in hippocampal synaptic membranes and expressed as fmoles/mg of
proteins. Results of ANOVA with repeated measures: HACU groups: F(1,16) = 5.15,
p = 0.0374∗, laterality: F(1,16) = 5.30, p = 0.0351∗, interaction: F(1,16) = 0.53,
p = 0.4791. [3H]HC:3 binding—groups: F(1,16) = 0.11, p = 0.7399, laterality:
F(1,16) = 0.41, p = 0.5307, interaction: F(1,16) = 0.47, p = 0.5007. ∗p < 0.050.
TABLE 4 | Correlation analysis of data from biochemical experiments.
Sham-operated Samaritan
Parameter vs. parameter r p r p Z-test
p
Subunits of NMDA receptors
NR1 R vs. Laterality NR1 −0.789 0.007∗∗ −0.976 < 0.001∗∗∗ 0.052
Laterality NR1vs. NR2B R 0.356 0.312 −0.692 0.057 0.037∗
Laterality NR1 vs. −0.245 0.495 0.72 0.044∗ 0.048∗
Laterality NR2B
NR2A R vs. Laterality NR2A −0.719 0.019∗ −0.702 0.052 0.953
NR2A L vs. Laterality NR2B −0.719 0.048∗ −0.86 0.006∗∗ 0.356
NR2B R vs. Laterality NR2B −0.979 < 0.001∗∗∗ −0.94 < 0.001∗∗∗ 0.361
NR2B L vs. Laterality NR2B 0.665 0.036∗ 0.878 0.004∗∗ 0.334
CHT1 transporters
HACU R vs. HACU L 0.686 0.041∗ 0.105 0.805 0.225
0.903 < 0.001∗∗∗ 0.676 0.065 0.271
NMDA subunits and CHT1
NR1 L vs. HACU L −0.6 0.088 0.595 0.119 0.023∗
Laterality NR1 vs. 0.438 0.238 0.935 < 0.001∗∗∗ 0.043∗
Laterality [3H]HC-3
NR2A R vs. Laterality HACU 0.711 0.032∗ 0.159 0.707 0.229
NR2A R vs. [3H]HC-3 L −0.584 0.099 0.488 0.22 0.047∗
NR2B R vs. HACU R −0.74 0.023∗ 0.151 0.757 0.074
NR2B L vs. [3H]HC-3 R −0.705 0.034∗ −0.473 0.236 0.549
Laterality NR2B vs. HACU R 0.684 0.042∗ −0.276 0.509 0.064
The laterality of particular parameters was expressed as indexes of laterality.
Correlation coefficients (r) were evaluated via a test based on Fisher’s
Z-transformation (Z-test). ∗p < 0.050, ∗∗p < 0.010, ∗∗∗p < 0.001.
were significant relationships between all subunit expression
levels in the R side and their laterality (three markedly negative
correlations), between NR2B expression in the L side and its
laterality (positive correlation), and finally between particular
subunits with respect to their laterality (between NR1 and NR2B
or between NR2A and NR2B). A comparison of controls and
Samaritan rats indicated two significant differences (a shift
from a positive to a negative correlation between the laterality
of NR1 and NR2B in the R side, a shift from negative to
a markedly positive correlation between the laterality of NR1
and the laterality of NR2B). With respect to CHT1, correlation
analysis revealed two marked positive correlations between
the R and L side in the controls (for HACU as well as
[3H]HC-3 binding); however, no differences between control
and Samaritan rats were found. Moreover, correlation analysis
revealed links between some subunits and CHT1 in sham-
operated controls (two positive correlations, between NR2A in
the R side and HACU laterality and between the laterality of
NR2B and HACU in the R side; two negative correlations,
between NR2B and HACU, both in the R side, and between
NR2B in the L side and [3H]HC-3 in the R side. A comparison of
control and Samaritan rats indicated three significant differences
(a shift from a negative to a positive correlation between
NR1 and HACU both in the L hemisphere, an increased
positive correlation between the laterality of NR1 and that of
[3H]HC-3, and finally a shift from a negative to a positive
correlation between NR2A in the R side and [3H]HC-3 in the
L side).
DISCUSSION
Impairments in the Morris Water Maze
Our results show that Samaritan rats were impaired in the
reference memory version of the MWM. They took longer
distances and times to reach the platform, and impairment was
also present in the probe trial, where the experimental group
had a significantly lower preference for the target quadrant
that had previously contained the platform. In the visible
platform testing, no significant difference between the groups
was found.
Memory impairments in the MWM are among the major
behavioral hallmarks of rodent models of AD. This task is a
generally recognized model of AD because it taps hippocampal
functions, which are among the first affected in human AD,
is very simple and is widely used in existing studies, making
it advantageous for comparisons of different models (for
review, see D’Hooge and De Deyn, 2001; Sabbagh et al.,
2013).
Although Lecanu et al. (2006) also examined MWM
performance in the Samaritan model, they only tested the effects
of experimental manipulations on the retrieval of memories
acquired prior to the surgery. Our experiments assessed the
ability to learn the reference memory task in rats already affected
by the ADmodel, as well as the ability (and accuracy) of retrieval
in a probe trial and the capability of the rats to master the
procedural aspects of the task.
Trials using a visible platform should assess the spatial
memory-independent aspects of the task, e.g., the capability to
swim, ability to perceive visual cues, procedural learning and
motivation to reach the platform. Although Figure 1A may
suggest a trend toward poorer performance in Samaritan rats,
the difference between the groups was not significant. It is also
possible that the animals partly relied on a spatial strategy even
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during the visible-platform test, as we did not change the visible
platform position across swims. Because swimming speed was
not altered in the Samaritan group (not shown), we can rule out
potential locomotor impairment in the AD model.
Deficits in Active Allothetic Place
Avoidance
Compared to the control group, we also observed a significant
deficit of Samaritan rats in the acquisition phase of the active
place avoidance test. No differences between groups were
detected in the habituation phase, when only distance was
evaluated (as there was no to-be-avoided sector). The lack of
differences between total distances in the habituation phase
(analogous to open field testing) suggests that spontaneous
locomotion in Samaritan rats is normal, and confirms that no
gross motoric impairments are present.
The deficits we found in the acquisition sessions (demanding
mainly so-called cognitive coordination), with Samaritan rats
showing a learning impairment, are a completely novel finding.
There was a clear difference between groups in all spatial
parameters (detected as significant interaction terms). The
significant interaction term found in the total distance in
acquisition sessions shows that control animals gradually
increased their distance, as they adopted an active strategy
enabling them to solve the task. The Samaritan rats exhibited
stable (and quite high) locomotion on all days, but they
nevertheless failed to reach the level of avoidance seen in the
control group.
We hypothesized that a deficit in cognitive coordination
would be present in the Samaritan rat model, because a meta-
analysis of the Stroop effect showed impaired processing of
multiple information streams in human AD patients (Ben-David
et al., 2014). The deficit we observed in active place avoidance
could be caused by a disruption of cognitive coordination;
however, a general impairment of spatial navigation andmemory
(as also observed in the MWM) is in itself sufficient to explain
the decreased performance in this task. Unfortunately, there are
no other studies on animal models of AD and their possible
deficits in cognitive coordination, so this question remains open
for future studies.
In the reversal sessions of active place avoidance, demanding
cognitive flexibility, we observed no significant differences
between groups. Here the situation is much more difficult
to interpret. From Figures 2B,C it is apparent that the
performance of the Samaritan group actually continued
to be worse even in the reversal sessions, although the
difference failed to reach statistical significance, probably
because the reversal performance was more variable. This
variability could be related to higher stress levels and/or
elevated cognitive demands. It is conceivable that the change
of sector position was relatively more disturbing for the
controls, which better remembered the original sector
position, than for the Samaritans, and this reduced the
apparent differences between them. Other observations from
our laboratory (Hatalova et al., 2014) may support such an
explanation.
Alterations in the Cortical Glutamatergic
and Hippocampal Cholinergic Systems
In the present study, we show that there are asymmetrical
differences in cortical NR2B subunit expression levels and in
the activity, rather than the number, of hippocampal CHT1
transporters in adult male Long Evans controls (compare
Tables 2, 3). Links between particular subunits of the NMDA
receptor or between the R and L sides in the case of
subunits/CHT1 could also be supported by our correlation
analyses (Table 4); however, these results should not be over-
interpreted since our experiments were not performed on
intact animals. Nevertheless, both results are in accordance
with observed lateral differences in hippocampal NR2B subunit
expression in mature mice (Kawakami et al., 2003) and in
hippocampal HACU in adult Long Evans rats (Kristofikova et al.,
2004, 2010), and so support the hypothesis that changes in
NMDA receptors and CHT1 transporters could be a molecular
basis for the structural and functional asymmetry of the mature
brain (Gibbs, 2000; Kawakami et al., 2003; Kristofikova et al.,
2004).
A comparison of Samaritan rats with controls revealed rather
unilateral changes in the frontal cortex (significantly increased
NR2A expression in the L side, see Table 2) but bilateral
alterations in the hippocampus (significantly increased HACU
levels in both hemispheres, see Table 3). Nevertheless, the
significant result of ANOVA with repeated measures for the
laterality of NR1 does not exclude moderate alterations in NR1
expression in the R side of the frontal cortex (in contrast to
NR2B, the effect of laterality in NR1 cannot be associated with
the asymmetry of this subunit in the controls). These results may
be also supported by significant correlation differences between
NR1 and NR2B (Table 4).
Since the NR2A subunit becomes more prevalent in
adulthood and with advanced aging (Cui et al., 2013) but is
markedly attenuated in the autoptic cortical or hippocampal
regions of people with AD (e.g., Hynd et al., 2004), our results
of increased NR2A expression in the frontal cortex of Samaritan
rats could be thus interpreted via the animal model mimicking
early rather than terminal stages of AD. Moreover, with respect
to the hyperactivity/hypoactivity of the glutamatergic system
observed in AD (Butterfield and Pocernich, 2003), the increased
NR2A subunit expression could reflect rather its hyperactivity
since NR2A-containing receptors have a lower activation energy
compared to those with NR2B (Erreger et al., 2005). We also
detected bilateral increases in the activity of CHT1 in Samaritan
rats compared to controls. Similar changes in CHT1 transporters
observed in Samaritan rats and in people in early stages of
AD (Slotkin et al., 1990) also support our above-mentioned
hypothesis that Samaritan rats could be a promising model of
sporadic AD, especially in its early stage.
Relationships Between Cortical NMDA
Receptors and Hippocampal CHT1
Our correlation analysis suggests complicated links between
the expression of NMDA receptors in the frontal cortex and
hippocampal CHT1 in the controls (Table 4). In particular, the
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data indicate possible connections between NR2A/NR2B and
CHT1 activity as well as between NR2B and the number of
CHT1; however, a more detailed analysis should be performed
in the future to correctly interpret this hypothesis. Nevertheless,
our results agree well with the reported role of prefrontal-
hippocampal pathways in cognitive/memory processes, and
perhaps also with the role of the R prefrontal cortex observed
in human- or non-human primates (Anderson et al., 2015). On
the other hand, an interpretation of changes in Samaritan rats
compared to controls is not difficult. Namely, higher positive
correlations between NR1 and CHT1 probably reflect similar
changes in the glutamatergic and cholinergic systems mediated
by applications of Abeta42 and the two pro-oxidative substances
into the L cerebral ventricle.
Study Limitations and Caveats
Despite what we feel are significant advances, our study is not
without limitations: First, we did not measure any classical
signs of AD pathology, such as amyloid plaques, neurofibrillary
tangles etc. Rather we strongly relied on the published results
of Lecanu et al. (2006) and the patented Samaritan model, and
we used already-operated animals. Second, we found a visual
trend to a worsening in performance in the visible platform
version of the MWM in Samaritan rats, which might suggest
some deficit in procedural aspects of the task (e.g., decreased
visual acuity or motivation), but we argue that such a deficit
only partially contributed to the deficit in the hidden platform
task. This interpretation is also supported by the fact that in the
active place avoidance task, which is procedurally very different
and less dependent on precise visual navigation, the cognitive
deficit of Samaritan rats was robust and manifested in multiple
parameters.
The Samaritan model itself is limited by the fact that it
exhibits only face validity (AD-like symptoms), but not construct
validity (similarities in etiology), as it is induced by the artificial
application of Abeta together with supplementary chemicals,
which is obviously not the case in actual AD. Furthermore, the
unilateral injection of the solution limits the validity of the model
with regard to lateralized changes in neurotransmitter systems.
However, as the etiology of sporadic AD remains enigmatic, most
of the existing models focus either on the familial form of the
disease, or must deal with similar issues.
CONCLUSION
In summary, our results corroborate the working hypothesis
that the Samaritan rat model of AD presents with deficits in
both behavioral parameters tested with two spatial tasks, as well
as alterations in the cortical glutamatergic and hippocampal
cholinergic systems. The deficit in cognitive functions in
Samaritan rats and the changes in NR2A subunit expression and
in CHT1 transporters support the notion that Samaritan rats
are a promising animal model of early-stage AD manifesting in
changes in behavior even in young adult rats, and a candidate
model of the sporadic form of the disease.
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